|
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands)
(»add to infobox)
| PERSONS (11/11) |
|
Bas BUENO DE MESQUITA (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
H. B. BUENO DE MESQUITA (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Marion KOOPMANS (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Kristin KREMER (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Robert LUTTIK (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Aldert PIERSMA (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Petrus Franciscus Maria TEUNIS (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Jan Willem VAN DER LAAN (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Marita VAN DER LAAR (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Dick VAN SOOLINGEN (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
Jacco WALLINGA (Contact / RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU (NL310 - Utrecht) (NL - Netherlands))
| RELATED THEMATIC AREAS (6/6) |
|
Across the area
Combating cardiovascular diseases, diabetes, and rare diseases
Developing new promising candidate vaccines and therapies
Development of new in vitro tests to replace animal experimentation
Health determinants and the provision of high quality and sustainable health care services and pension systems
Public health issues
| RELATED PROJECTS (12/12) |
|
INTERACT - An examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes (Life sciences, genomics and biotechnology for health)
EPIGENCHLAMYDIA - Contribution of molecular epidemiology and host-pathogen genomics to understand Chlamydial trachomatis disease (Life sciences, genomics and biotechnology for health)
TB-DRUG OLIGOCOLOR - Development of a molecular platform for the simultaneous detection of Mycobacterium tuberculosis resistance to rifampicin and fluoroquinolones (Life sciences, genomics and biotechnology for health)
REPROTECT - Development of a novel approach in hazard and risk assessment or reproductive toxicity by a combination and application of in vitro, tissue and sensor technologies (Life sciences, genomics and biotechnology for health)
TBADAPT - Effect of genetic variation in Mycobacterium tuberculosis on vaccine escape and the acquisition of drug resistance. (Life sciences, genomics and biotechnology for health)
SARSCONTROL - Effective and Acceptable Strategies for the Control of SARS in China and Europe (Policy-orientated research)
EPIC - European Prospective Investigation into Cancer, Chronic Diseases, Nutrition and Lifestyle (Policy-orientated research)
POLYMOD - Improving Public Health Policy in Europe through Modelling and Economic Evaluation of Interventions for the Control of Infectious Diseases (Policy-orientated research)
RETHINK - Minipigs as models for the toxicity testing of new medicines and chemicals: impact assessment (Life sciences, genomics and biotechnology for health)
EVENT - Providing tools to prevent emergence of enteric viruses (Policy-orientated research)
RAINBOW - Research on Animal and In vitro studies and Numerical methods: Bridging Opportunities through a Workshop (Life sciences, genomics and biotechnology for health)
TUBERCULOSIS CHINA - The diversity of Mycobacterium tuberculosis strains in China: tracing the origins of the worldwide dispersion of the multidrug-resistant Beijing genotype (Life sciences, genomics and biotechnology for health)
|
|
|
LifeCompetence operated by AVEDAS
Contact: support@avedas.com
|
